About
MiMedx is a biomedical company based in Marietta, Georgia, founded in 2008. The company specializes in developing and commercializing placental tissue-based products for regenerative medicine, wound care, and surgical recovery. MiMedx utilizes human birth tissues, including the placenta, amniotic sac, and umbilical cord, to create biologic products that support healing and tissue regeneration. The company offers a range of proprietary products, including EpiFix, AmnioFix, EpiCord, AmnioCord, and DuraMatrix. These products are designed to promote healing by providing scaffolds for tissue regeneration, reducing inflammation, and minimizing scar tissue formation. MiMedx primarily serves healthcare professionals and institutions involved in wound care management, surgical recovery, and orthopedic and neurosurgical applications. Their mission is to help clinicians manage chronic wounds and improve patient outcomes through innovative healing solutions.
Technologies
Keywords
Company Information
-
Employees 840
-
Founded 2008
-
Annual Revenue $348879000
-
Total Funding $141080000
Location
1775 W Oak Commons Ct NE, Marietta, Georgia, United States, 30062